Glycopeptide-Induced Neutropenia: Cross-Reactivity Between Vancomycin and Teicoplanin

Abstract

Spanish

French

Objective:

To report teicoplanin-related neutropenia that developed after an episode of neutropenia induced by vancomycin therapy.

Case Summary:

A 57-year-old female suffered from osteomyelitis of the left humerus, with a white blood cell (WBC) count of 2.8 × 10³/mm³ and absolute neutrophil count (ANC) of 0.28 × 10³/mm³, occurring after 24 days of vancomycin therapy. Vancomycin was changed to teicoplanin and the agranulocytosis resolved 4 days later. However, a new episode of neutropenia, with a WBC count of 2.8 × 10³/mm³ and ANC of 0.448 × 10³/mm³, occurred 11 days after teicoplanin initiation. Agranulocytosis resolved 4 days following withdrawal of teicoplanin.

Discussion:

Because of the close time relationship between drug administration and the development of symptoms and signs, as well as between drug withdrawal and changes in WBC count and ANC, the episodes of neutropenia were suspected to be drug related. Teicoplanin-induced agranulocytosis that followed vancomycin-induced agranulocytosis suggests a possible cross-reactivity between the 2 drugs. Both reactions were categorized as probable according to the Naranjo probability scale.

Conclusions:

For all patients with vancomycin-induced neutropenia, possible cross-reactivity of teicoplanin should be monitored.

Keywords

cross-reactivity glycopeptide neutropenia teicoplanin vancomycin

Get full access to this article

View all access options for this article.

References

de Lalla

Tramarin

. A risk-benefit assessment of teicoplanin in the treatment of infections. Drug Saf 1995;13:317–28.

Van Bambeke

Van Laethem

Courvalin

Tulkens

. Glycopeptide antibiotics: from conventional molecules to new derivatives. Drugs 2004;64:913–36. DOI 10.2165/00003495-200464090-00001

Del Favero

Patoia

Bucaneve

Biscarini

Menichetti

. Leukopenia with neutropenia associated with teicoplanin therapy. DICP 1989;23:45–7.

Farber

Moellering

Jr. . Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother 1983;23:138–41.

Morris

Ward

. High incidence of vancomycin-associated leucopenia and neutropenia in a cardiothoracic surgical unit. J Infect 1991;22:217–23. DOI 10.1016/S0163-4453(05)80002-7

Pai

Mercier

Koster

. Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy. Ann Pharmacother 2006;40:224–8. Epub 24 Jan 2006. DOI 10.1345/aph.1G436

LeFrock

Ristuccia

. Teicoplanin in the treatment of bone and joint infections: an open study. J Infect Chemother 1999;5:32–9. DOI 10.1007/S101560050005

Pauluzzi

Del Favero

Menichetti

. Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study. J Antimicrob Chemother 1987;20:431–8.

Calain

Krause

Vaudaux

. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. J Infect Dis 1987;155:187–91.

10.

Naranjo

Busto

Sellers

. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–45.

11.

Young

Gleeson

Cripps

. C-reactive protein: a critical review. Pathology 1991;23:118–24.

12.

Segarra-Newnham

Tagoff

. Probable vancomycin-induced neutropenia. Ann Pharmacother 2004;38:1855–9. Epub 5 Oct 2004. DOI 10.1345/aph.1E187

13.

Schwartz

. Vancomycin-induced neutropenia in a patient positive for an antineutrophil antibody. Pharmacotherapy 2002;22:783–8. DOI 10.1592/phco.22.9.783.34059

14.

Sanche

Dust

Shevchuk

. Vancomycin-induced neutropenia resolves after substitution with teicoplanin. Clin Infect Dis 2000;31:824–5. DOI 10.1086/314028

15.

Kirkwood

Smith

Rustagi

Schentag

. Neutropenia associated with beta-lactam antibiotics. Clin Pharm 1983;2:569–78.

16.

McElrath

Goldberg

Neu

. Allergic cross-reactivity of teicoplanin and vancomycin (letter). Lancet 1986;1:47.

17.

Knudsen

Pedersen

. IgE-mediated reaction to vancomycin and teicoplanin after treatment with vancomycin. Scand J Infect Dis 1992;24:395–6.

18.

Davenport

. Allergic cross-reactivity to teicoplanin and vancomycin (letter). Nephron 1993;63:482.

19.

Marshall

Street

Galbraith

. Glycopeptide-induced vasculitis—cross-reactivity between vancomycin and teicoplanin. J Infect 1998;37:82–3. DOI 10.1016/S0163-4453(98)91077-5

20.

Khurana

de Belder

. Red-man syndrome after vancomycin: potential cross-reactivity with teicoplanin. Postgrad Med J 1999;75:41–3.

21.

Padial

Barranco

Lopez-Serrano

. Erythema multiforme to vancomycin (letter). Allergy 2000;55:1201. DOI 10.1034/j.1398-9995.2000.00549.x